Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT06900738 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT06900738
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • The person joining (or their legal representative) must have given written agreement to take part before any screening begins.
  • People who are at least 18 years old at the time of signing the consent form.
  • People who have been diagnosed with Crohn's disease, ulcerative colitis, or a related inflammatory bowel disease that is unclassified (sometimes called IBDU).
  • People who are either in hospital or being seen as outpatients, with currently active inflammatory bowel disease — meaning their disease activity scores and blood or stool test results meet certain thresholds set by the trial (confirm with trial site for exact values).
  • People who have access to a smartphone (either iPhone/iOS or Android) with internet access.
  • Outpatient participants will be recruited in a way that keeps the balance between genders within a roughly 40–60 split (confirm with trial site).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently pregnant.
  • People who have a known allergy to steel or elastomer/rubber materials.
  • People who use a pacemaker, an implantable cardiac defibrillator, a neurostimulator, or any other implanted or worn electronic medical device.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 016342845

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Correlation of the the PPG signal with any dynamic biomarker

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov